Clinical Trials
42 trialsARCADIAN
University of Oxford
Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma
Jonsson Comprehensive Cancer Center
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Jazz Pharmaceuticals
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis
Northwestern University
NVB Metro
Assistance Publique Hopitaux De Marseille
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients
Baylor Research Institute
Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer
Case Comprehensive Cancer Center
CTC-TCM-FZ
Shanghai University of Traditional Chinese Medicine
Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Swiss Cancer Institute
Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors
Puma Biotechnology, Inc.
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
Medical University of South Carolina
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
University of Washington
Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer
GlaxoSmithKline
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
Stanford University
A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.
Hoffmann-La Roche
PROVIN
Assistance Publique Hopitaux De Marseille
Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC
Sanofi
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
University of Southern California
VENUS-1
Aktion Bronchialkarzinom e.V.
VENUS-2
Aktion Bronchialkarzinom e.V.
CELAVIE
Sponsor GmbH
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer
University of Chicago
Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma
Istituto Clinico Humanitas
Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer
UNICANCER
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia
Memorial Sloan Kettering Cancer Center
Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer
National Cancer Centre, Singapore
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Northwestern University
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
National Cancer Institute (NCI)
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
University of Chicago
Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer
Dartmouth-Hitchcock Medical Center
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
Dana-Farber Cancer Institute
Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer
National Cancer Centre, Singapore
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
University of California, Davis
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
Mast Therapeutics, Inc.
METRO1
Institut Paoli-Calmettes
Satraplatin and Vinorelbine in Advanced Solid Tumors
Southern Europe New Drug Organization
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer
Institut Claudius Regaud
Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer
Hellenic Oncology Research Group
Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies
Metronome Therapeutics
Vinorelbine and XR9576 to Treat Cancer
National Institutes of Health Clinical Center (CC)